Status:

COMPLETED

Physical Therapy and Neuroactive Steroids Therapy Does Not Modulate Serum Level of Neuroactive Steroids

Lead Sponsor:

Charles University, Czech Republic

Conditions:

Multiple Sclerosis

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

This study describes modulation of neuroproprioceptive facilitation and inhibition physical therapy on serum level of neuroactive steroids in multiple sclerosis.

Detailed Description

In the parallel group, single blind, randomized controlled trial, participant underwent two kinds of neuroproprioceptive PT (MPAT and VRL). At baseline and after the end of the two months' therapeutic...

Eligibility Criteria

Inclusion

  • prevailed spastic paraparesis, stable clinical status and treatment in the preceding 3 months determined by neurologist,
  • Expanded Disability Status Scale score (EDSS) max. 7.5

Exclusion

  • other neurological disease or conditions disabling movement

Key Trial Info

Start Date :

May 20 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2019

Estimated Enrollment :

63 Patients enrolled

Trial Details

Trial ID

NCT04379193

Start Date

May 20 2015

End Date

September 1 2019

Last Update

May 7 2020

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.